Annual Report

Overview

The report describes a resilient but challenged FY25, with operating revenue of $21.8M and 24,642 commercial tests despite Medicare coverage uncertainty. Cxbladder Triage was included in the American Urological Association microhematuria guideline with a Grade A evidence rating. Sustainability highlights include a 5.9% reduction in emissions intensity, a 20% FY29 intensity-reduction target, and independent limited assurance of Scope 1 and Scope 2 emissions.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: Ends 31 March 2025
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Provider
Level
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services